New England Biolabs (NEB), a provider in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Korea Ltd. (NEB Korea).
The Impetus for NEB Korea
The Republic of Korea is emerging as a global leader in the life science space, as a result of strong public sector support and private sector investments, the company says. NEB has supported researchers in South Korea for many years through its distribution network.
“This new subsidiary office will provide the scientific research community in South Korea with more efficient access to the latest NEB products and technical support in the local time zone, as well as custom partnership opportunities,” says Elin Yoon, country manager for NEB Korea. “We are excited to bring this level of support to our customers, and to help accelerate their research.”
Supporting the Korean Market
NEB Korea aims to bring a higher level of service to its customers and local distributors in this market.
“It’s been encouraging to see the rapid growth of South Korea’s life science industry over the past few years, which is a testament to the country’s relentless focus on laying the groundwork for new technologies and advancements,” says Carole Keating, executive director of International Business at NEB. “The expansion of our subsidiary network enables NEB to offer even greater personalized service to our customers, rapid delivery, and the ability to explore higher levels of collaboration.”
Further reading: New England Biolabs Opens Applications for Passion in Science Awards
NEB also maintains subsidiary offices in Australia, Canada, China, France, Germany, Japan, New Zealand, Singapore, and the United Kingdom.